http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109021061-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_579f59a45d643999ae11b6be32528182
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J73-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J73-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2018-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_617353f099d8f9f63ef7e68d4b9b71bf
publicationDate 2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109021061-A
titleOfInvention Triptolide targeting prodrug and its preparation method and application
abstract The invention relates to the technical field of medicine, in particular to a prodrug of triptolide targeting inducible nitric oxide synthase (iNOS) and its preparation method and application. The R of the triptolide targeting prodrug is L-arginine, L-arginine methyl ester, L-N ω -NO-arginine, L-N ω -NO-arginine methyl ester , L-guanidine, L-thioguanine, L-lysine or L-ornithine. The present invention utilizes the characteristics of high expression of inducible nitric oxide synthase (iNOS) at the site of inflammation, uses iNOS specific substrate (group) to semi-synthesize triptolide to prepare prodrug, and reduces triptolide prodrug through its targeting properties. Toxicity and bioavailability of rattolide are improved, and its anti-inflammatory effect is significantly better than that of triptolide, which can realize the effective development and utilization of triptolide.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110229210-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110229210-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111518157-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113480590-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113480590-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109762038-A
priorityDate 2018-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017070878-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102786576-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008087202-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015085447-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163843585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465562823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465715822
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163948500

Total number of triples: 34.